Infiltrating Urothelial Carcinoma, Sarcomatoid Variant
1 clinical trials · Condition
◉ Watch Infiltrating Urothelial Carcinoma, Sarcomatoid Variant
| Record | Firm | Date |
|---|---|---|
| Tremelimumab + Durvalumab(MEDI4736)+ Belinostat in Urothelial Carcinoma (NCT05154994) | University of Utah | 2022-01-14 |
Track Infiltrating Urothelial Carcinoma, Sarcomatoid Variant automatically
Every clearance here is in the API, with alerts when new ones post.